Faculty of Science, Technology and Engineering, La Trobe University, Melbourne, Australia.
J Mol Graph Model. 2013 Jul;44:44-53. doi: 10.1016/j.jmgm.2013.05.002. Epub 2013 May 14.
The effects of different protonation states of the hydroxamic acid (HA) inhibitors against the class I histone deacetylase enzymes (HDACs) have been studied using the state of the art quantum polarized ligand docking (QPLD) and molecular mechanics-generalized Born surface area (MM-GBSA) approaches. The binding modes of the inhibitors and their inter-molecular interactions with class I HDACs, in response to the protonation states of the inhibitors, are explored. Our results indicate that the different protonation states of the inhibitors exhibit significant differences in their interactions with the catalytic zinc metal ion and the other active site residues in the HDAC enzymes, which in turn affect the 'Histidine-Aspartate' charge relay mechanism. The QPLD calculations show that the protonated states of the inhibitors display higher scores in all the class I HDACs in this study, while the deprotonated forms present lower scores. The molecular electrostatic potentials and the other physico-chemical descriptors support the results. The MM-GBSA approach employed in the present work has been able to accurately calculate the relative binding free energies of the neutral and the protonated HA inhibitors; those were close to the experimental values. However, the MM-GBSA approach breaks down while calculating the binding free energies of the deprotonated inhibitors, which resulted in unrealistic values. Large energetic differences were found in the polar electrostatic solvation energy terms and the coulombic contributions in the deprotonated inhibitors. Thus improvements in the present solvation models and force fields become inevitable for the inclusions of charged states of inhibitors in computational drug discovery.
已使用最先进的量子极化配体对接(QPLD)和分子力学-广义 Born 表面积(MM-GBSA)方法研究了羟肟酸(HA)抑制剂不同质子化状态对 I 类组蛋白去乙酰化酶(HDAC)的影响。探索了抑制剂的结合模式及其与 I 类 HDAC 之间的分子间相互作用,以响应抑制剂的质子化状态。我们的结果表明,抑制剂的不同质子化状态在与 HDAC 酶中的催化锌金属离子和其他活性位点残基的相互作用中表现出显著差异,这反过来又影响了“组氨酸-天冬氨酸”电荷中继机制。QPLD 计算表明,在本研究中的所有 I 类 HDAC 中,抑制剂的质子化状态显示出更高的分数,而去质子化形式的分数则较低。分子静电势和其他物理化学描述符支持这些结果。本工作中采用的 MM-GBSA 方法能够准确计算中性和质子化 HA 抑制剂的相对结合自由能;这些与实验值接近。然而,当计算去质子化抑制剂的结合自由能时,MM-GBSA 方法会失效,导致不切实际的值。在去质子化抑制剂中,发现极性静电溶剂化能项和库仑贡献之间存在较大的能量差异。因此,对于在计算药物发现中包含抑制剂的带电状态,改进目前的溶剂化模型和力场变得不可避免。